| TGF-β and cancer | 2006/02/01 | English | 297 |
| Targeting the extrinsic apoptosis pathway in cancer | 2008/06/01 | English | 293 |
| Molecular interactions of the IGF system | 2005/08/01 | English | 290 |
| Interferon-γ: A historical perspective | 2009/04/01 | English | 289 |
| RET tyrosine kinase signaling in development and cancer | 2005/08/01 | English | 288 |
| The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity | 2013/06/01 | English | 285 |
| Leukemia inhibitory factor (LIF) | 2015/10/01 | English | 285 |
| Fibroblast growth factor signaling in tumorigenesis | 2005/04/01 | English | 285 |
| PDGF signaling in cells and mice | 2004/08/01 | English | 283 |
| COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons | 2020/06/01 | English | 281 |
| CXC chemokines in angiogenesis | 2005/12/01 | English | 277 |
| Tumor suppressor activity of the TGF-β pathway in human cancers | 1996/06/01 | English | 277 |
| Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis | 2008/04/01 | English | 277 |
| Plasticity and cross-talk of Interleukin 6-type cytokines | 2012/06/01 | English | 276 |
| The chemokine system in cancer biology and therapy | 2010/02/01 | English | 273 |
| Cytokine and cytokine receptor gene polymorphisms and their functionality | 2009/02/01 | English | 272 |
| Delivery of bone morphogenetic proteins for orthopedic tissue regeneration | 2005/06/01 | English | 268 |
| IL-15/IL-15 receptor biology: A guided tour through an expanding universe | 2006/08/01 | English | 259 |
| High-mobility group box 1 (HMGB1) protein: Friend and foe | 2006/06/01 | English | 255 |
| BMP2 signaling in bone development and repair | 2009/10/01 | English | 254 |
| The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine | 2019/04/01 | English | 254 |
| Insight into the physiological functions of PDGF through genetic studies in mice | 2004/08/01 | English | 245 |
| Transforming growth factor beta (TGF-β) and inflammation in cancer | 2010/02/01 | English | 245 |
| The emerging role of adipokines as mediators of inflammation and immune responses | 2007/06/01 | English | 243 |
| SOST/sclerostin, an osteocyte-derived negative regulator of bone formation | 2005/06/01 | English | 241 |
| Cell biology of IL-7, a key lymphotrophin | 2005/08/01 | English | 240 |
| Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis | 2006/02/01 | English | 235 |
| The role of ephrins and Eph receptors in cancer | 2004/12/01 | English | 235 |
| Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history | 2008/02/01 | English | 235 |
| Chemokine receptors: Structure, function and role in microbial pathogenesis | 1996/06/01 | English | 235 |